Cargando…
TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion
Reperfusion therapy for acute ischemic stroke aims to restore the blood flow of occluded blood vessels. However, successful recanalization is often associated with disruption of the blood-brain barrier, leading to reperfusion injury. Delayed recanalization increases the risk of severe reperfusion in...
Autores principales: | Chen, Bo, Wei, Shunhui, Low, See Wee, Poore, Charlene Priscilla, Lee, Andy Thiam-Huat, Nilius, Bernd, Liao, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216476/ https://www.ncbi.nlm.nih.gov/pubmed/37239151 http://dx.doi.org/10.3390/biomedicines11051480 |
Ejemplares similares
-
Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia
por: Wei, Shunhui, et al.
Publicado: (2020) -
Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M
por: Wei, Shunhui, et al.
Publicado: (2022) -
SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury
por: Wei, Shunhui, et al.
Publicado: (2023) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
por: Low, See Wee, et al.
Publicado: (2021) -
TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke
por: Chen, Bo, et al.
Publicado: (2019)